cytarabine has been researched along with Pulmonary Hypertension in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hidaka, T; Koga, H; Miyako, K; Suga, N; Takahashi, N | 1 |
| Hong-eng, S; Limsuwan, A; Pakakasama, S; Rochanawutanon, M | 1 |
2 other study(ies) available for cytarabine and Pulmonary Hypertension
| Article | Year |
|---|---|
Improving circulatory disturbance in transient abnormal myelopoiesis.
Topics: Antimetabolites, Antineoplastic; Blood Transfusion; Cytarabine; Down Syndrome; Fatal Outcome; GATA1 Transcription Factor; Humans; Hypertension, Pulmonary; Infant, Newborn; Infant, Newborn, Diseases; Liver Failure; Male; Mutation; Myelopoiesis; Renal Insufficiency | 2012 |
Pulmonary arterial hypertension after childhood cancer therapy and bone marrow transplantation.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bone Marrow Transplantation; Cyclophosphamide; Cytarabine; Female; Humans; Hyperplasia; Hypertension, Pulmonary; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Vasodilator Agents | 2006 |